Cancer Genetics Inc (NASDAQ:CGIX)

1.00
Delayed Data
As of Apr 23
 -0.10 / -9.09%
Today’s Change
0.90
Today|||52-Week Range
4.78
-45.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues7.0M6.6M8.0M7.5M
 
 
 
 
 
Cost of Goods Sold3.6M3.5M4.1M4.7M
 
 
 
 
 
Depreciation And Amortization617.0K530.0K523.0K495.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.8M2.6M3.4M2.3M
 
 
 
 
 
General Expenses5.5M5.7M6.5M11.8M
 
 
 
 
 
Research And Development1.1M982.0K979.0K1.7M
 
 
 
 
 
Total Operating Expenses9.8M9.7M11.1M17.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.8M-3.1M-3.0M-9.5M
 
 
 
 
 
Extraordinary Credit0.00590.0K2.9M2.1M
 
 
 
 
Extraordinary Charge-7.5M0.00-150.0K0.00
 
 
 
Pre-Tax Equity Earnings-12.0K-7.0K-2.0K-1.0K
 
 
 
 
 
Interest Expense On Debt194.0K253.0K350.0K1.4M
 
 
 
 
 
Other Expenses-46.0K0.000.00-220.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.6M-2.8M-633.0K-9.0M
 
 
 
 
 
Income Taxes-970.0K0.000.00-1.1M
 
 
 
Net Income-9.6M-2.8M-633.0K-7.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.9M19.7M21.6M27.8M
 
 
 
 
 
Shares To Calculate EPS Diluted18.9M20.7M22.4M27.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.51-$0.16-$0.15-$0.35
 
 
 
 
 
EPS Diluted-$0.51-$0.16-$0.15-$0.28